Advertisement
Screener

Gartner, Inc. (IT) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate

3.2 / 5 stars · 76/120 Roast Me

Gartner, Inc. Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate

Gartner, Inc. (IT) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate of 3.50% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate · last filed 2026-02-12

  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, weighted-average interest crediting rate for fiscal 2025 was 3.50%, a 12.90% increase from fiscal 2024.
  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, weighted-average interest crediting rate for fiscal 2024 was 3.10%, a 13.89% decline from fiscal 2023.
  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, weighted-average interest crediting rate for fiscal 2023 was 3.60%, a 200.00% increase from fiscal 2022.
  • Gartner, Inc. defined benefit plan, assumptions used calculating net periodic benefit cost, weighted-average interest crediting rate for fiscal 2022 was 1.20%, a 50.00% increase from fiscal 2021.
Period endDefined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate 12 month
2025-12-313.50%
10-K · filed 2026-02-12
2024-12-313.10%
10-K · filed 2026-02-12
2023-12-313.60%
10-K · filed 2026-02-12
2022-12-311.20%
10-K · filed 2025-02-13
2021-12-310.80%
10-K · filed 2024-02-15
2020-12-311.20%
10-K · filed 2023-02-16
2019-12-311.90%
10-K · filed 2022-02-23
2018-12-311.90%
10-K · filed 2021-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evolent Health, Inc. (EVH)United States$0.397B-1.21
FRANKLIN COVEY CO (FC)United States$0.195B123.76